Quantification of total body bioluminescence imaging (BLI) counts showed a profound decrease in metastasis in mice injected with MSC-primed ABL-knockdown lung cancer cells compared to mice injected with MSC-primed control cells (Fig 7B–7E). The gene discussed is ABL1; the disease is lung cancer.